![The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains: Molecular Therapy The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains: Molecular Therapy](https://www.cell.com/cms/asset/00cc3813-dbaf-475c-bb5e-32c77a4213e6/fx1.jpg)
The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains: Molecular Therapy
![Antibody-secreting plasma cells with unique CD5 <sup>+</sup>IgG<sup>+</sup>CD21lo phenotype developed in humanized NOG mice Antibody-secreting plasma cells with unique CD5 <sup>+</sup>IgG<sup>+</sup>CD21lo phenotype developed in humanized NOG mice](https://www.oatext.com/img/CRT-2-138-Figure-6.jpg)
Antibody-secreting plasma cells with unique CD5 <sup>+</sup>IgG<sup>+</sup>CD21lo phenotype developed in humanized NOG mice
![Frontiers | CD5 Surface Expression Marks Intravascular Human Innate Lymphoid Cells That Have a Distinct Ontogeny and Migrate to the Lung Frontiers | CD5 Surface Expression Marks Intravascular Human Innate Lymphoid Cells That Have a Distinct Ontogeny and Migrate to the Lung](https://www.frontiersin.org/files/Articles/752104/fimmu-12-752104-HTML-r1/image_m/fimmu-12-752104-g001.jpg)
Frontiers | CD5 Surface Expression Marks Intravascular Human Innate Lymphoid Cells That Have a Distinct Ontogeny and Migrate to the Lung
![T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape | Signal Transduction and Targeted Therapy T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-022-00898-z/MediaObjects/41392_2022_898_Fig1_HTML.png)
T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape | Signal Transduction and Targeted Therapy
![Alteration of Cell Surface Markers CD38 and CD138 in Lymphoproliferative Disorders in the Ocular Adnexa | Anticancer Research Alteration of Cell Surface Markers CD38 and CD138 in Lymphoproliferative Disorders in the Ocular Adnexa | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/40/4/2019/F2.large.jpg)
Alteration of Cell Surface Markers CD38 and CD138 in Lymphoproliferative Disorders in the Ocular Adnexa | Anticancer Research
![CD5 (Mantle Cell Lymphoma Marker) Ultraspecific Antibody Tested against >20,000 Human Proteins – enQuire BioReagents CD5 (Mantle Cell Lymphoma Marker) Ultraspecific Antibody Tested against >20,000 Human Proteins – enQuire BioReagents](https://enquirebio.com/wp-content/uploads/2018/06/enQuire-Bio-921-MSM6-P0-anti-CD5-Mantle-Cell-Lymphoma-Marker-antibody.jpeg)
CD5 (Mantle Cell Lymphoma Marker) Ultraspecific Antibody Tested against >20,000 Human Proteins – enQuire BioReagents
![Expression of surface membrane markers on B-CLL cells and normal CD5 ؉... | Download Scientific Diagram Expression of surface membrane markers on B-CLL cells and normal CD5 ؉... | Download Scientific Diagram](https://www.researchgate.net/publication/11360352/figure/fig2/AS:281749927022611@1444185825802/Expression-of-surface-membrane-markers-on-B-CLL-cells-and-normal-CD5-B-cells-Surface.png)
Expression of surface membrane markers on B-CLL cells and normal CD5 ؉... | Download Scientific Diagram
![JCM | Free Full-Text | Characterization and Potential Applications of Dog Natural Killer Cells in Cancer Immunotherapy JCM | Free Full-Text | Characterization and Potential Applications of Dog Natural Killer Cells in Cancer Immunotherapy](https://pub.mdpi-res.com/jcm/jcm-08-01802/article_deploy/html/images/jcm-08-01802-g001.png?1575027904)
JCM | Free Full-Text | Characterization and Potential Applications of Dog Natural Killer Cells in Cancer Immunotherapy
![The frequencies of peripheral blood CD5+CD19+ B cells, CD3−CD16+CD56+ NK, and CD3+CD56+ NKT cells and serum interleukin-10 in patients with multiple sclerosis and neuromyelitis optica spectrum disorder | Allergy, Asthma & Clinical The frequencies of peripheral blood CD5+CD19+ B cells, CD3−CD16+CD56+ NK, and CD3+CD56+ NKT cells and serum interleukin-10 in patients with multiple sclerosis and neuromyelitis optica spectrum disorder | Allergy, Asthma & Clinical](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13223-021-00596-5/MediaObjects/13223_2021_596_Fig2_HTML.png)
The frequencies of peripheral blood CD5+CD19+ B cells, CD3−CD16+CD56+ NK, and CD3+CD56+ NKT cells and serum interleukin-10 in patients with multiple sclerosis and neuromyelitis optica spectrum disorder | Allergy, Asthma & Clinical
![Biomedicines | Free Full-Text | The Forgotten Brother: The Innate-like B1 Cell in Multiple Sclerosis Biomedicines | Free Full-Text | The Forgotten Brother: The Innate-like B1 Cell in Multiple Sclerosis](https://pub.mdpi-res.com/biomedicines/biomedicines-10-00606/article_deploy/html/images/biomedicines-10-00606-g001.png?1646739920)
Biomedicines | Free Full-Text | The Forgotten Brother: The Innate-like B1 Cell in Multiple Sclerosis
![Dynamic variation of CD5 surface expression levels within individual chronic lymphocytic leukemia clones - ScienceDirect Dynamic variation of CD5 surface expression levels within individual chronic lymphocytic leukemia clones - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0301472X16306221-gr1.jpg)
Dynamic variation of CD5 surface expression levels within individual chronic lymphocytic leukemia clones - ScienceDirect
![T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape | Signal Transduction and Targeted Therapy T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape | Signal Transduction and Targeted Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-022-00898-z/MediaObjects/41392_2022_898_Fig2_HTML.png)
T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape | Signal Transduction and Targeted Therapy
![CD5 dynamically calibrates basal NF-κB signaling in T cells during thymic development and peripheral activation | PNAS CD5 dynamically calibrates basal NF-κB signaling in T cells during thymic development and peripheral activation | PNAS](https://www.pnas.org/cms/10.1073/pnas.1922525117/asset/5dbe6f58-e09e-4f55-b99d-4f99d60605dc/assets/graphic/pnas.1922525117fig01.jpeg)
CD5 dynamically calibrates basal NF-κB signaling in T cells during thymic development and peripheral activation | PNAS
![Expression of T cell surface markers on CD5 KO and WT mouse TIL. A, TIL... | Download Scientific Diagram Expression of T cell surface markers on CD5 KO and WT mouse TIL. A, TIL... | Download Scientific Diagram](https://www.researchgate.net/publication/51175016/figure/fig4/AS:667848812793856@1536238973030/Expression-of-T-cell-surface-markers-on-CD5-KO-and-WT-mouse-TIL-A-TIL-from-a-pool-of.png)
Expression of T cell surface markers on CD5 KO and WT mouse TIL. A, TIL... | Download Scientific Diagram
![Cells | Free Full-Text | Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents Cells | Free Full-Text | Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents](https://pub.mdpi-res.com/cells/cells-09-02589/article_deploy/html/images/cells-09-02589-g001.png?1607108098)